Annual Meeting

Venue

The 31st Annual Meeting of the American Society for Bone and Mineral Research will take place September 11 - 15, 2009, at the Colorado Convention Center in Denver, Coloarado, USA.

Back to Top

Awards

Abstracts-Related Awards

Only first/presenting authors will be considered for the following awards. Although nominations are not accepted for the following awards, abstract submitters should indicate their eligibility on the abstract submission form.

ASBMR Young Investigator Awards
These awards recognize young investigators who submit top-ranking abstracts to the ASBMR Annual Meeting. Award recipients will receive a $1,000 honorarium and a plaque. The ASBMR expects that $500 of the honorarium will be used to help offset travel expenses to the ASBMR Annual Meeting. The other $500 may be used by the recipient at his/her discretion. Eligible applicants must:

• Be the first and presenting author of the abstract
• Be a student/trainee or within five years of completion of a Ph.D., M.D., residency training or equivalent*
• NOT be a past recipient of an ASBMR Young Investigator Award

*The five years of eligibility are defined to extend from the end of the calendar year of the date of graduation or, if applicable, of completion of residency training or clinical subspecialty fellowship training, to the submission deadline date. Clinical subspecialty fellowship training is considered to end no later than the point at which the individual becomes board eligible. To petition for an extension of eligibility, please contact the ASBMR prior to the abstract submission deadline, April 14, 2009.

The ASBMR Most Outstanding Abstract Award is given to the highest ranking abstract. The award includes a $1,500 honorarium and a plaque. (One award is given per year).

The ASBMR Award for Outstanding Research in the Pathophysiology of Osteoporosis is given to the highest ranking abstract in the Osteoporosis: Pathophysiology abstract category.  The award includes a $1,500 honorarium and a plaque. (One award is given per year).

The ASBMR President's Award is given to the highest ranking abstract by a student. The award includes a $1,500 honorarium and a plaque. (One award is given per year).

Other ASBMR Awards

ASBMR will present other major Society awards at the meeting that recognize individuals for their outstanding work in the field of bone and mineral research and for dedication to the Society (Louis V. Avioli Founders Award, Fuller Albright Award, Frederic C. Bartter Award, William F. Neuman Award, Shirley Hohl Service Award, the Gideon A. Rodan Excellence in Mentorship Award, and the ASBMR Early Career Excellence in Teaching Award). The deadline for these awards have passed, thank you for your nominations. For further information, contact the ASBMR Business Office at (202) 367-1161 or visit the ASMBR Awards page.

Back to Top

Continuing Medical Education (CME)

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Federation of American Societies for Experimental Biology (FASEB) and the American Society for Bone and Mineral Research (ASBMR). The Federation of American Societies for Experimental Biology is accredited by the ACCME to provide continuing medical education for physicians.

FASEB designates this educational activity for a maximum of 31 AMA PRA Category 1 Credits™

Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME application forms will be available online beginning September 11, 2009. Please Note: FASEB charges a $45 fee per application. Should you have questions, contact the FASEB Office of Scientific Meetings and Conferences, 9650 Rockville Pike, Bethesda, MD 20814, +1 301-643-7010; email: fasebcme@faseb.org

Meeting Objectives

At the end of the program, participants should be able to:

• Discuss the most current and significant advances in biomedical and clinical research in bone and mineral metabolism, specifically in the areas of cancer and bone, mineral metabolism, genetics, bioengineering, osteoporosis, metabolic bone diseases and therapeutics.
• Better understand the interrelationship among basic research, clinical research and patient care.
• Improve their ability to treat and care for their patients through an enhanced knowledge of osteoporosis, other diseases of bone, basic bone biology and its correlation to mineral metabolism.
• Develop new and enhanced strategies for the diagnosis and treatment of patients with disorders of bone and mineral metabolism.

Intended Audience

The program is designed for researchers, physicians, clinicians, and other allied health professionals with interests in endocrinology, physiology, cell biology, pathology, molecular biology, genetics, epidemiology, internal medicine, rheumatology, orthopaedics, dentistry, nephrology, and pharmacology.

Disclosure Policy

The Federation of American Societies for Experimental Biology (FASEB) requires that audiences at FASEB-sponsored educational programs be informed of a presenter's (speaker, faculty, author, or contributor) academic and professional affiliation, and the existence of any relevant financial relationship a presenter has with any proprietary entity producing health care goods or services consumed by, or used on patients, with the exemption of non-profit or government organizations and non-health care related companies. The intent of this disclosure is not to prevent a speaker from making a presentation. This policy allows the listener/attendee to be fully knowledgeable in evaluating the information being presented.

Disclosure should include any relationship that may bias one's presentation or which, if known, could give the perception of bias. These situations may include, but are not limited to: 1) Stock Options or Bond Holdings in a for-profit Corporation or Self-directed Pension Plan; 2) Research Grants; 3) Employment (full or part-time); 4) Ownership or Partnership; 5) Consulting Fees or Other Remuneration (payment); 6) Non-remunerative Positions of Influence Such as Officer, Board Member, Trustee, or Public Spokesperson; 7) Receipt of Royalties; 8) Speaker's Bureau; 9) Other

ASBMR’s Expectation of Authors and Presenters

Through ASBMR meetings, the Society promotes excellence in bone and mineral research. To that end, ASBMR expects that all authors and presenters affiliated with the ASBMR 31st Annual Meeting and the 2009 Ancillary Program will provide informative and fully accurate content that reflects the highest level of scientific rigor and integrity. This includes the presentations at the 2009 Ancillary Meetings ¾ the International Society for Clinical Densitometry (ISCD) Courses, the Industry Supported Symposia (ISS) and Working Groups.

The ASBMR depends upon the honesty of the authors and presenters and relies on their assertions that they have had sufficient full access to the data and are convinced of its reliability.

Furthermore, the ASBMR expects that:

• Authors and presenters will disclose any conflicts of interest, real or perceived.
• Authors of an abstract describing a study funded by an organization with a proprietary or financial interest must affirm that they had full access to all the data in the study. By so doing, they accept complete responsibility for the integrity of the data and the accuracy of the data analysis.
• The content of abstracts, presentations, slides and reference materials must remain the ultimate responsibility of the author(s) or faculty.
• The planning, content and execution of abstracts, speaker presentations, slides, abstracts and reference materials should be free from corporate influence, bias, or control.
• All authors and presenters (invited and abstracts-based oral and poster presenters) should give a balanced view of therapeutic options by providing several treatment options, whenever possible, and by always citing the best available evidence.

ASBMR Embargo Policy

Abstracts submitted to the ASBMR 31st Annual Meeting are embargoed — that is, unavailable for public release in written, oral and electronic communications — until one hour after the abstract has been presented.

The ASBMR is sensitive to issues of commercial confidentiality and relevant aspects of the U.S. Securities and Exchange Commission (SEC) regulations. Therefore, the ASBMR reminds all readers that all must adhere to the U.S. Securities and Exchange Commission regulations and treat all scientific information as confidential until the embargo has been lifted – one hour after the abstract has been presented. Any reader of, or listener to, ASBMR Annual Meeting content may be viewed as an “insider” by the SEC due to knowledge of information included in abstracts, particularly clinical trial abstracts. SEC regulations may call for criminal penalties for using such information.

Back to Top

2009 Supporters

The ASBMR gratefully acknowledges the following companies and organizations for their support:

Diamond Level
Amgen, Inc.
Eli Lilly and Company

Silver Level
Alliance for Better Bone Health (Procter & Gamble Pharmaceuticals and sanofi-aventis)
Roche and GSK

Bronze Level
Novartis Pharmaceuticals Corporation

Friend Level
Immunodiagnostic Systems, Inc.
National Dairy Council
Procter & Gamble Pharmaceuticals
sanofi-aventis
Scanco USA
Wyeth Pharmaceuticals

Back to Top

Advertising

If you are interested in learning about advertising opportunities in the Journal of Bone and Mineral Research, please contact:

Steve Kavalgian
Mill River Media
Phone: (860) 434-6889,
Fax: (860) 434-9744,
E-mail: millrivermedia@aol.com,
Website: www.jbmr-online.org

Back to Top